LEVEMIR

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug LEVEMIR contains one active pharmaceutical ingredient (API):

1 Insulin detemir
UNII 4FT78T86XV - INSULIN DETEMIR

Insulin detemir is a soluble, long-acting insulin analogue with a prolonged duration of effect used as a basal insulin.

Read about Insulin detemir

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LEVEMIR Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10AE05 Insulin detemir A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 12236B, 9040T
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526602101153419, 526602102151411, 526602103156210
Country: CA Health Products and Food Branch Identifier(s): 02271842, 02412829
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 28527-08-08
Country: EE Ravimiamet Identifier(s): 1208001, 1208012, 1208023, 1208034, 1208045, 1208056, 1208067, 1208078, 1208089, 1639144, 1639155, 1639166
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 04278005, 04278008
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 019718, 019758, 094310
Country: FR Base de données publique des médicaments Identifier(s): 64529525, 66481292, 66688750
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 111482, 75895, 75900
Country: HK Department of Health Drug Office Identifier(s): 53538, 65011
Country: IE Health Products Regulatory Authority Identifier(s): 63003, 63005, 63015, 63082, 63109
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4811, 6587
Country: IT Agenzia del Farmaco Identifier(s): 036850016, 036850028, 036850030, 036850042, 036850055, 036850067, 036850079, 036850081, 036850093
Country: JP 医薬品医療機器総合機構 Identifier(s): 2492417A1038, 2492417G1030, 2492417G2029
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004369, 1029390, 1029391, 1029392, 1029393, 1029394, 1029395, 1029396, 1029397, 1054649, 1054650, 1064133, 1064134, 1064135, 1064136, 1064137
Country: NL Z-Index G-Standaard Identifier(s): 14719509, 14941260
Country: NL Z-Index G-Standaard, PRK Identifier(s): 75140, 75159
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11102, 11104
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100127134
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W41731001, W41731002, W41731003, W41732001, W41732002, W41732003, W52352001, W52352002, W52352003
Country: SG Health Sciences Authority Identifier(s): 13115P, 15515P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5993071
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699676950782, 8699676950799
Country: US FDA, National Drug Code Identifier(s): 0169-3687, 0169-6438, 50090-1276, 50090-4501
Country: ZA Health Products Regulatory Authority Identifier(s): 38/21.1/0084

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.